Mandate

Vinge advises Nordic Paper Holding AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Nordic Paper Holding AB (publ) (“Nordic Paper” or the “Company”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 12 October 2020 and the first day of trading on Nasdaq Stockholm was 22 October 2020.

The price in the offering was SEK 43 per share, corresponding to a market capitalisation of all of Nordic Paper’s shares upon completion of the offering of approximately SEK 2,877 million. The offering comprised 34,123,488 existing shares, of which all were offered by Shanying International Holding Co., Ltd. (through Sutriv Holding AB).

Nordic Paper is a producer of specialty paper with a leading position within kraft paper and natural greaseproof paper. The Company operates through four production sites located in Säffle, Greåker, Bäckhammar and Åmotfors, which manufacture high quality pulp and paper with an annual total production capacity of 286 ktonnes paper, whereas the volume of paper sold in 2019 amounted to 264 ktonnes. Nordic Paper has approximately 700 customers located in approximately 70 countries and close to 95 per cent of the Company’s manufactured paper is exported.

Vinge’s team primarily consisted of David Andersson, Malte St Cyr Ohm, Boris Kotur, Amanda M Johansson and Emil Lindwall (Capital Markets and Public M&A), Jonas Bergström, Milad Kamali and Clara Sohlberg (M&A), Johan Cederblad and Olof Löfvenberg (Environmental law), Albert Wållgren and Pauline Lagerstrand and Felix Möller (Banking and Finance), Maria Schultzberg and Victor Ericsson (Corporate tax), Sara Strandberg (Employment and Benefits), Lisa Hörnqvist (Corporate Commercial), Mia Falk and Anders Leissner (Compliance), as well as Jessica Öijer (VDR specialist).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026